BR0318688A - polipeptìdeo para o diagnóstico e terapia de leishmania - Google Patents

polipeptìdeo para o diagnóstico e terapia de leishmania

Info

Publication number
BR0318688A
BR0318688A BRPI0318688-1A BR0318688A BR0318688A BR 0318688 A BR0318688 A BR 0318688A BR 0318688 A BR0318688 A BR 0318688A BR 0318688 A BR0318688 A BR 0318688A
Authority
BR
Brazil
Prior art keywords
leishmania
seq
indian
strains
leishmanial
Prior art date
Application number
BRPI0318688-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Sarman Singh
Ramu Sivakumar
Original Assignee
All India Inst Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by All India Inst Med filed Critical All India Inst Med
Publication of BR0318688A publication Critical patent/BR0318688A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0318688-1A 2003-12-26 2003-12-26 polipeptìdeo para o diagnóstico e terapia de leishmania BR0318688A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000400 WO2005063803A1 (fr) 2003-12-26 2003-12-26 Polypeptides pour le diagnostic et la therapie de la leishmaniase

Publications (1)

Publication Number Publication Date
BR0318688A true BR0318688A (pt) 2006-12-19

Family

ID=34717534

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0318688-1A BR0318688A (pt) 2003-12-26 2003-12-26 polipeptìdeo para o diagnóstico e terapia de leishmania

Country Status (9)

Country Link
US (1) US7740859B2 (fr)
EP (1) EP1711520B1 (fr)
CN (1) CN100480265C (fr)
AT (1) ATE457316T1 (fr)
AU (1) AU2003288711A1 (fr)
BR (1) BR0318688A (fr)
DE (1) DE60331266D1 (fr)
ES (1) ES2345046T3 (fr)
WO (1) WO2005063803A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0904621A2 (pt) 2008-07-25 2015-06-30 Dept Of Biotechnology India Quimera recombinante de construção de dna
CN102590508A (zh) * 2012-03-12 2012-07-18 中国疾病预防控制中心寄生虫病预防控制所 检测亲内脏利什曼原虫感染和诊断黑热病的免疫层析试条
WO2016055836A1 (fr) * 2014-10-09 2016-04-14 Universidade Federal De Minas Gerais - Ufmg Procédé de production et d'utilisation de la protéine rk39-kddr et trousse pour le diagnostic de la leishmaniose
EP4422675A2 (fr) * 2021-10-28 2024-09-04 Vida Pharmacal, Inc. Procédé et composition d'antigène pour la détection rapide de la maladie de chagas, de la leishmaniose et/ou du ver du coeur chez l'homme et l'animal

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411865A (en) 1993-01-15 1995-05-02 Iasys Corporation Method of detecting anti-leishmania parasite antibodies
US5912166A (en) 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
US5834592A (en) 1995-09-22 1998-11-10 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6855522B2 (en) 2002-02-27 2005-02-15 Indian Council Of Medical Research Species-specific PCR assay for detection of Leishmania donovani in clinical samples of kala-azar and post kala-azar dermal leishmaniasis

Also Published As

Publication number Publication date
ES2345046T3 (es) 2010-09-14
CN1910197A (zh) 2007-02-07
US7740859B2 (en) 2010-06-22
WO2005063803A1 (fr) 2005-07-14
EP1711520B1 (fr) 2010-02-10
US20080031878A1 (en) 2008-02-07
AU2003288711A1 (en) 2005-07-21
EP1711520A1 (fr) 2006-10-18
CN100480265C (zh) 2009-04-22
DE60331266D1 (de) 2010-03-25
ATE457316T1 (de) 2010-02-15

Similar Documents

Publication Publication Date Title
DE60202877D1 (de) Gezieltes antikörper-verfahren
BR9917218A (pt) Anticorpos monoclonais, antìgenos, e diagnósticoe terapia de doenças malignas
Cheng et al. Characterization of a novel merozoite surface protein of Plasmodium vivax, Pv41
Costa et al. New serological tools for improved diagnosis of human tegumentary leishmaniasis
Chenik et al. Approaches for the identification of potential excreted/secreted proteins of Leishmania major parasites
Ohta et al. Research on calpain of Schistosoma japonicum as a vaccine candidate
Ebrahimzadeh et al. The incidence of current infection with different human malaria species by polymerase chain reaction for diagnosis of suspicious malaria patients on elimination region Sistan and Baluchistan province, southeast of Iran
Lima et al. Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individuals
EP2877196A1 (fr) Ompa et asp14 dans des compositions de vaccin et en tant que cibles de diagnostic
BR0318688A (pt) polipeptìdeo para o diagnóstico e terapia de leishmania
CN107551264B (zh) L3和/或l5源作为寄生虫病疫苗或诊断的用途
WO2004020609A3 (fr) Antigenes streptococcus pneumoniae pour le diagnostic, le traitement et la prevention d'infections evolutives
Hans et al. Identification and characterization of a novel Plasmodium falciparum adhesin involved in erythrocyte invasion
EP1869073B1 (fr) Polypeptides de leishmania major, polynucleotides codant ces polypeptides, et leur applications a des fins vaccinales, therapeutiques ou diagnostiques
Benhnini et al. Comparative evaluation of two vaccine candidates against experimental leishmaniasis due to Leishmania major infection in four inbred mouse strains
Boldbaatar et al. Detection of antibodies to Hypoderma lineatum in cattle by Western blotting with recombinant hypodermin C antigen
Iraqi Diagnostic value of semi-purified antigens of hydatid cyst fluid in human cystic echinococcosis
AU2667600A (en) Identification of specific differentially expressed antigens
US10197577B2 (en) Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines
de Pádua Vidigal et al. Enzyme immunoassay using Leishmania (Viannia) braziliensis antigens for laboratorial diagnosis of American cutaneous leishmaniasis
WO2010108245A3 (fr) Utilisation d'antigènes de leishmania dans une méthode diagnostique, vaccin et traitement contre la leishmaniose
Kashino et al. Identification of Leishmania infantum chagasi proteins in urine of patients with visceral leishmaniasis: a promising antigen discovery approach of vaccine candidates
Jaiswal et al. Immunological consequences of stress-related proteins–cytosolic tryparedoxin peroxidase and chaperonin TCP20–identified in splenic amastigotes of Leishmania donovani as Th1 stimulatory, in experimental visceral leishmaniasis
WO2003080839A3 (fr) Fragments antigeniques destines au diagnostic de toxoplasma gondii
AU2018217443B2 (en) Hybrid peptide, set of hybrid peptides, composition, uses of the hybrid peptide, method for inducing an immune response and kits

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.